Oxytocin, often dubbed the "love hormone," is known to promote social bonding. Researchers at KU Leuven have now discovered that administering oxytocin to adult men with autism makes them more open to close emotional bonds ...
Jan 22, 2020
1
476
Anthracyclines remain a cornerstone of breast cancer therapy in combination with new-generation targeted drugs such as trastuzumab. Both types of drugs are major culprits in chemotherapy-induced heart disease. A recent study ...
Dec 23, 2019
0
2
(HealthDay)—For patients with early-stage breast cancer, 10-year outcomes are similar for treatment with partial breast irradiation (PBI) and whole breast irradiation (WBI), according to a study presented at the annual ...
Dec 12, 2019
0
1
A shorter course of higher-dose radiation treatment to part of the breast is showing promise in women with early-stage breast cancer who undergo breast conserving surgery, says a study led by Hamilton researchers.
Dec 5, 2019
0
10
Women with early-stage breast cancer that has a specific pattern of gene expression are more likely than others to benefit from treatment with a class of common but potentially harmful chemotherapy drugs called anthracyclines, ...
Nov 8, 2019
0
44
Natural language processing, the technology that lets computers read, decipher, understand and make sense of human language, is the driving force behind internet search engines, email filters, digital assistants such as Amazon's ...
Nov 7, 2019
0
28
Women are significantly less likely than men to be awarded grants and New Investigator personnel awards from the Canadian Institutes of Health Research (CIHR), according to a new study published this week in PLOS Medicine ...
Oct 22, 2019
0
4
Although graduating from school, a first job and marriage can be important events in life, some of the most significant events happen far earlier: in the first few days after a sperm fertilizes an egg and the cell begins ...
Oct 17, 2019
0
60
New data presented at the ESMO Congress 2019 in Barcelona, Spain, show the benefit of a more intensive maintenance regimen for ovarian cancer with the PARP inhibitor olaparib added to bevacizumab, in an all-comers population, ...
Sep 28, 2019
0
5
In just one year, around 115,000 cancer patients in England are diagnosed too late to give them the best chance of survival, according to new calculations from Cancer Research UK released today.
Sep 2, 2019
0
0
